| Source Date | Board Meeting Date | Details |
|
06-Nov-2025
|
13-Nov-2025
|
Quarterly Results
|
|
05-Aug-2025
|
12-Aug-2025
|
Quarterly Results
|
|
14-May-2025
|
22-May-2025
|
Audited Results
|
|
28-Feb-2025
|
26-Feb-2025
|
Inter alia, to consider and approve a proposal for issue of equity shares and / or convertible securities and / or any other eligible securities, on preferential basis or any other permissible mode / and / or combination thereof as may be considered appropriate as per the relevant provisions of SEBI (Issue of Capital and Disclosure Requirements) Regulations 2018, as amended, subject to all such regulatory / statutory approvals as may be required.
|
|
21-Feb-2025
|
26-Feb-2025
|
Inter alia, to consider a proposal for issue of equity shares and / or convertible securities and / or any other eligible securities, on preferential basis or any other permissible mode / and / or combination thereof as may be considered appropriate as per the relevant provisions of SEBI (Issue of Capital and Disclosure Requirements) Regulations 2018, as amended, subject to all such regulatory / statutory approvals as may be required.
|
|
04-Feb-2025
|
14-Feb-2025
|
Quarterly Results
|
|
05-Nov-2024
|
12-Nov-2024
|
Quarterly Results
|
|
06-Aug-2024
|
13-Aug-2024
|
Quarterly Results
|
|
14-May-2024
|
30-May-2024
|
Audited Results
|
|
01-Feb-2024
|
09-Feb-2024
|
Quarterly Results
|
|
02-Nov-2023
|
09-Nov-2023
|
Quarterly Results
|
|
28-Jul-2023
|
07-Aug-2023
|
Quarterly Results
|
|
23-May-2023
|
29-May-2023
|
Audited Results
|
|
16-Mar-2023
|
30-Mar-2023
|
Emami Realty Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/03/2023 ,inter alia, to consider and approve change in terms of outstanding instruments / issuance of Non-Convertible Securities, subject to regulatory and other statutory approvals as may be required, including approval of the shareholders of the Company. Further, the Trading Window of the Company for dealing in securities of the Company shall be closed from 15th March, 2023 till the end of 48 hours after the declaration of Audited Financial Results of the Company for the year ended 31st March, 2023.
|
|
15-Mar-2023
|
31-Mar-2023
|
(Revised) Inter-alia, to consider change in terms of outstanding instruments / issuance of Non- Convertible Securities, subject to regulatory and other statutory approvals as may be required, including approval of the shareholders of the Company
|
|
07-Feb-2023
|
14-Feb-2023
|
Quarterly Results
|
|
09-Jan-2023
|
12-Jan-2023
|
Inter alia, to consider and approve Proposal for issuance of debenture securities convertible into equity shares on preferential / private placement basis, subject to regulatory and other statutory approvals as may be required, including approval of the shareholders of the Company.
|
|
07-Nov-2022
|
14-Nov-2022
|
Quarterly Results
|
|
02-Aug-2022
|
09-Aug-2022
|
Quarterly Results
|
|
16-May-2022
|
24-May-2022
|
Quarterly Results & Audited Results
|